Hormone Treatment, Estrogen Receptor Polymorphisms and Mortality: A Prospective Cohort Study

• Joanne Ryan ,

  * E-mail: joanne.ryan@inserm.fr

  Affiliation Inserm U1061, Université Montpellier 1, Montpellier, France

  ⨯
• Marianne Canonico,

  Affiliation Inserm U1018, Université Paris Sud 11, UMRS 1018, F-94807, Villejuif, France

  ⨯
• Laure Carcaillon,

  Affiliations Inserm U1018, Université Paris Sud 11, UMRS 1018, F-94807, Villejuif, France, Inserm U897, Université Bordeaux 2, Bordeaux, France

  ⨯
• Isabelle Carrière,

  Affiliation Inserm U1061, Université Montpellier 1, Montpellier, France

  ⨯
• Jacqueline Scali,

  Affiliation Inserm U1061, Université Montpellier 1, Montpellier, France

  ⨯
• Jean-Francois Dartigues,

  Affiliation Inserm U897, Université Bordeaux 2, Bordeaux, France

  ⨯
• Carole Dufouil,

  Affiliation Inserm U708, Paris, France

  ⨯
• Karen Ritchie,

  Affiliations Inserm U1061, Université Montpellier 1, Montpellier, France, Faculty of Medicine, Imperial College, London, United Kingdom

  ⨯
• Pierre-Yves Scarabin,

  Affiliation Inserm U1018, Université Paris Sud 11, UMRS 1018, F-94807, Villejuif, France

  ⨯
• Marie-Laure Ancelin

  Affiliation Inserm U1061, Université Montpellier 1, Montpellier, France

  ⨯